For more than 30 years, Texcell provides comprehensive, standard protocols for evaluating your cell banks, raw materials and cell derivatives such as monoclonal antibodies, recombinant proteins, vaccines and gene therapy products.

To ensure the safety of your biotherapeutic product, Texcell offers a vast array of services and tests. Every study is designed in accordance with the EU or US Pharmacopoeia and EMEA or FDA guidelines. All studies are performed in accordance to GLP or GMP-guidelines.

Against Covid19, Texcell offers a broad range of SARS-COV-2 / Covid19 testings. Check out Texcell’s offer here. Our protocols can be customized to meet your needs.